News

The Manila Times3d
Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study
QRX003 is being well tolerated by the patient and no adverse events have been reported. As a result of these positive initial ...
The Manila Times4d
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results
Announced Positive Clinical Data for Adult and Pediatric Netherton Patients ASHBURN, Va., May 13, 2025 (GLOBE NEWSWIRE) -- ...